CDKN2A, also known as cyclin-dependent kinase inhibitor 2A by binding to cyclin-dependent kinases (CDKs), acts as a tumor suppressor by blocking the cell cycle from G1 to S phase (41). The gene discussed is CDKN2A; the disease is neoplasm.